Please join TEI and Thomson Reuters for an in-depth presentation on the federal income tax treatment of research and experimental (R&E) expenditures under section 174, as amended by the Tax Cuts and Jobs Act. This webinar will cover the treatment of these expenditures, including substantive and technical considerations and the new revenue procedures published by the IRS.
During this webinar the panelists will discuss:
- Section 174 costs
- Nuances of ambiguous areas related to the section 174
- Technical and procedural issues in computing section 174 costs
Presenters:
- Mark Hindes – Senior Manager, Deloitte
- Paige Riordan – Director of Tax Credits, Massie Tax Credits
Moderator:
- Kelly Madigan- Tax Counsel, Tax Executives Institute
Additional Information
Objectives of the webinar: Upon successful completion of the webinar, attendees will be able to recognize key federal income tax treatment of research and experimental (R&E) expenditures under section 174, as amended by the Tax Cuts and Jobs Act.
Prerequisites: None
Program Level: Basic
Advance Preparation: None
Delivery method: Group Internet Based
In order to be awarded the full credits, you must be in attendance throughout the duration of the webinar and respond to five out of the six polling questions asked during the program.